Drug Approval | August 31, 2022
Granules now have a total of 51 ANDA approvals from US FDA (49 Final approvals and 2 tentative approvals).
This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
Perrigo expects to launch Omeprazole Minis later this year
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
Subscribe To Our Newsletter & Stay Updated
